CAPECITABINE-D11
- CAS No.
- 1132662-08-8
- Chemical Name:
- CAPECITABINE-D11
- Synonyms
- Xeloda-d11;Captabin-d11;Capiibine-d11;Ro 09-1978-d11;Capecytabine-d11;Capecitibine-d11;CAPECITABINE-D11;Ro 09-1978/000-d11;[2H11]-Capecitabine;2’-O-(5’-Deoxy-?-D-ribofuranosyl) Capecitabine-d11
- CBNumber:
- CB8457758
- Molecular Formula:
- C15H13D11FN3O6
- Molecular Weight:
- 372.43
- MDL Number:
- MFCD10567126
- MOL File:
- Mol file
- MSDS File:
- SDS
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS08 |
---|---|
Signal word | Danger |
Hazard statements | H341-H350-H360-H402 |
Precautionary statements | P201-P202-P273-P280-P308+P313-P405-P501 |
CAPECITABINE-D11 price More Price(9)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Cayman Chemical | 10010681 | Capecitabine-d11 ≥99% deuterated forms (d1-d11) | 1132662-08-8 | 1mg | $299 | 2024-03-01 | Buy |
Cayman Chemical | 10010681 | Capecitabine-d11 ≥99% deuterated forms (d1-d11) | 1132662-08-8 | 5mg | $595 | 2024-03-01 | Buy |
TRC | C175652 | Capecitabine-d11 | 1132662-08-8 | 5mg | $350 | 2021-12-16 | Buy |
Usbiological | C1077-05A | Capecitabine-d11 | 1132662-08-8 | 1mg | $425 | 2021-12-16 | Buy |
TRC | C175652 | Capecitabine-d11 | 1132662-08-8 | 10mg | $580 | 2021-12-16 | Buy |
CAPECITABINE-D11 Chemical Properties,Uses,Production
Description
Capecitabine-d11 is intended for use as an internal standard for the quantification of capecitabine by GC- or LC-MS. Capecitabine is a prodrug form of 5-fluorouracil (5-FU). It is converted to 5-FU via several enzymatic steps beginning in the liver and ending with conversion in tumor tissue by thymidine phosphorylase, an enzyme that is more concentrated in tumor tissue compared with normal tissue. Capecitabine is cytotoxic only at high concentrations in Scaber, SIHA, and MKN45 cells (IC50s = 97, 578, and 994 μM, respectively) and is inactive in a variety of cancer cell lines, including COLO 205, HCT116, and MCF-7 cells (IC50s = >1,000 μM).
Chemical Properties
Off-White Powder
Uses
Capecitabine D11 is an isotopically labelled antineoplastic agent. A prodrug of Doxifluridine.;Labeled Capecitabine, intended for use as an internal standard for the quantification of Capecitabine by GC- or LC-mass spectrometry.
Uses
An isotopically labelled antineoplastic agent. A prodrug of Doxifluridine (D556750).
CAPECITABINE-D11 Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Hubei Jusheng Technology Co.,Ltd. | 18871490254 | linda@hubeijusheng.com | CHINA | 28172 | 58 |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 | sales@conier.com | China | 49374 | 58 |
SIMSON PHARMA LIMITED | +91-8291074273 | k.das@simsonpharma.com | India | 228 | 58 |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49734 | 58 |
TargetMol Chemicals Inc. | support@targetmol.com | United States | 38632 | 58 | |
J & K SCIENTIFIC LTD. | 010-82848833 400-666-7788 | jkinfo@jkchemical.com | China | 96815 | 76 |
3B Pharmachem (Wuhan) International Co.,Ltd. | 821-50328103-801 18930552037 | 3bsc@sina.com | China | 15839 | 69 |
Chemsky(shanghai)International Co.,Ltd. | 021-50135380 | shchemsky@sina.com | China | 32321 | 50 |
Cato Research Chemicals Inc. | 020-81960175 | min.he@cato-chem.com | China | 1955 | 55 |
Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9806 | 58 |
View Lastest Price from CAPECITABINE-D11 manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
2024-10-24 | Capecitabine-d11
1132662-08-8
|
US $0.00-0.00 / mg | 10g | TargetMol Chemicals Inc. | ||||
2023-05-27 | Capecitabine-D11
1132662-08-8
|
US $0.00-0.00 / mg | 1mg | 96% | 50mg | Simson Pharma limited |
- Capecitabine-d11
1132662-08-8
- US $0.00-0.00 / mg
- TargetMol Chemicals Inc.
- Capecitabine-D11
1132662-08-8
- US $0.00-0.00 / mg
- 96%
- Simson Pharma limited